Biotech

Dynavax to Host Analyst & Investor Day Webcast October 27, 2011

BERKELEY, CA: BERKELEY, CA -- (Marketwire) -- 10/12/11 -- Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that it will webcast its 2011 Analyst & Investor Day on Thursday, October 27, 2011, fr ...

Media Advisory/REMINDER: Theratechnologies to Announce Financial Results for Third Quarter of 2011

MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwire) -- 10/12/11 -- Theratechnologies Inc. (TSX: TH)(NASDAQ: THER) (Theratechnologies) announced today that it will issue its financial results for the third quarter of 2 ...

Ceapro Announces Signing of a Sales Agreement With Ross Organic Specialty Sales Inc. for its certified All-Natural Active Ingredients in the Western United States

EDMONTON, ALBERTA: EDMONTON, ALBERTA -- (Marketwire) -- 10/12/11 -- Ceapro Inc. (TSX VENTURE: CZO) ("Ceapro" or "the Company") is pleased to announce today the signing of a new sales agreement with ...

Thallion Resuming Patient Recruitment in Phase II SHIGATEC Trial

MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwire) -- 10/11/11 -- Thallion Pharmaceuticals Inc. (TSX: TLN) announced today that it is resuming patient enrollment in the Company's Phase II SHIGATEC trial.In July, ...

Aeolus Pharmaceuticals Announces $12.7 Million NIH Counteract Grant Award to Continue Development of AEOL 10150 as a Treatment Against Chlorine and Sulfur Mustard Gas Exposure

MISSION VIEJO, CA: MISSION VIEJO, CA -- (Marketwire) -- 10/10/11 -- Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (PINKSHEETS: AOLS), a biotechnology company that is leveraging up to $140M of government funding in develo ...

Validation and cGMP Consulting Services, by ValSource LLC, a Feature of "Industry Today" on Industrialinfo.com

SUGAR LAND, TX: SUGAR LAND, TX -- (Marketwire) -- 10/10/11 -- Industrial Info will host special guest (Downingtown, Pennsylvania) as part of this week's "Industry Today" webcast. ValSource is a lead ...

Paladin Labs Completes Acquisition of Labopharm

MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwire) -- 10/07/11 -- Paladin Labs Inc. (TSX: PLB), a leading Canadian specialty pharmaceutical company, today announced that it has completed its previously announced acqu ...

Dynavax Reports Diabetic Subset Data From Modified Intent to Treat Analysis of the HEPLISAV(TM) Phase 3 Trial in Healthy Adults Over Age 40

BERKELEY, CA: BERKELEY, CA -- (Marketwire) -- 10/06/11 -- Dynavax Technologies Corporation (NASDAQ: DVAX) announced today the results of a prospective analysis of the diabetic subset population from its Phase 3 t ...

RXT 110 INC. Announces the Appointment of Directors to Fill Vacancies on the Board

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwire) -- 10/06/11 -- RXT 110 INC. (CNSX: RXT) (the "Company") announced today the appointment of Mr. Allan S. Gibbins and Mr. David Butler to serve as directors ...

Theratechnologies Identifies Second Generation GRF Peptide and Initiates Pre-Clinical Studies

MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwire) -- 10/06/11 -- Theratechnologies Inc. (TSX: TH) (NASDAQ: THER) announced today that it has discovered a new growth-hormone releasing factor (GRF) peptide with simila ...